Research & Education

IASLC European Webinar Series - 2015/2016 - Biomarkers and Personalized Medicine for Patients with Lung Cancer

Thursday, July 14, 2015 - 6 p.m. BST - Recording Available

In this session, Prof. Keith Kerr updates a webinar first presented last year, on developments in personalized medicine for patients with lung cancer, the impact that this has had, and could have in the future, for those patients, and how the pursuit of biomarkers to predict response to targeted therapy has changed lung cancer diagnostics.

Radiation Webinar - Making Progress in Stage III NSCLC Management

Thursday, July 9, 2015 - 6 p.m. AEST / 10 a.m. CEST - Recording Available

The IASLC Education Committee is pleased to announce the continuation of a series of Live Webinars presented by the Advanced Radiation Technology Committee. This subcommittee is focused on providing educational and informational programs addressing state of the art radiation therapy for lung cancer. This live program will be moderated by Francoise Mornex, MD, PhD and feature presentations by Professor David Ball and Professor Michael Mac Manus

Current Role of Immunotherapy for Lung Cancer

Thursday, June 25, 2015 at 9 p.m. ET - Recording Available

In this special report, Dr. Scott Gettinger provides an in-depth look at the evolving role of immunotherapeutics in the clinical management of advanced non small cell lung cancer. The most recent data from the 2015 Annual Meeting of the American Society of Clinical Oncology will be highlighted.

The evolving role of PD-1/PD-L1 inhibitors in the clinical management of non-small cell lung cancer

Wednesday, June 10, 2015 9 p.m. ET - Recording Available

This presentation will inform the participant about emerging data regarding inhibitors of PD-1 and PD-L1. Agents discussed will include those that are FDA approved for non-small cell lung cancer, as well as those for which there is data available but no current approval. Topics to be addressed will include data with respect to efficacy, safety, and proposed approaches to select patients most likely to have clinical benefit with these agents

New Therapies Are Coming for Malignant Pleural Mesothelioma - 14th Webinar: IASLC Lung Cancer Grand Rounds Series

Thursday, April 2, 2015 - Recording Available

IASLC is holding a LIVE WEBINAR featuring Dr. Lee Krug. This session will begin with a discussion regarding the current standard approach for evaluation and treatment of a patient with malignant pleural mesothelioma.

E-Cigarettes: Friend or Foe?

Wednesday, April 1, 2015 - Recording Available

IASLC Smoking Cessation and Tobacco Control LIVE Webinar featuring Drs. Maciej Goniewicz and Ben Toll with Dr. Matthew Steliga as the moderator.

Chemotherapy Options for Metastatic Lung Cancer - 13th Webinar: IASLC Lung Cancer Grand Rounds Series

March 11, 2015 at 9 p.m. EDT - Recording Available

IASLC is holding a LIVE WEBINAR featuring Dr. Mark Socinski. During this live webinar, Dr. Socinski will address the issues and considerations relative to the selection of chemotherapy options for patients with advanced stage non-small cell lung cancer.

Advances in Non-Small Cell Lung Cancer: Approaches to the management of TKI resistance and the role of T790M emergence

Tuesday, February 25, 2015 - Recording Available

IASLC is holding a LIVE WEBINAR featuring Dr. Jonathan Goldman and Dr. Heather Wakelee

Smoking, Cessation, and the Cancer Patient: Clinical, Biologic, and Behavioral Considerations

Wednesday, January 21, 2015 - Recording Available

This webinar will discuss the known biological effects of smoking on cancer cell biology and emphasize the clinical effects of continued smoking in patients with lung cancer treated with surgery, chemotherapy and/or radiotherapy.er Patients: Addressing the Evidence about Tobacco Use and Cancer Treatment

12th Webinar: IASLC Lung Cancer Grand Rounds Series - Best of 2014 Lung Cancer Research and High Priority NCI Lung Cancer Trials

Tuesday, January 20, 2015 - Recording Available

The Twelfth webinar in the series: IASLC Grand Rounds Series - Best of 2014 Lung Cancer Research and High Priority NCI Lung Cancer Trials.

Pages